NCT03338868

Serum Concentrations, Physical and Psychological Well-being in Metabolic Syndrome

Comparison of Serum Concentrations, Physical and Psychological Well-being in Patients Having Chronic Musculoskeletal Pain With and Without Metabolic Syndrome

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 100 (estimated)
• Sponsor: Ataturk Training and Research Hospital · Academic / Other
• Sex: All
• Age: 20 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study was to investigate the serum concentrations, physical and psychological well-being characteristics in patients having chronic musculoskeletal pain with metabolic syndrome, and to compare patients without metabolic syndrome.

Detailed description

Metabolic syndrome (MetS) is a combination of metabolic risk factors such as impaired glucose level, dyslipidemia, hypertension, and central obesity. MetS has become a large public health issue with common interrelation to different accompanying disorders. Moreover, the link between MetS and musculoskeletal disorders has previously been demonstrated. Presence and prevalence of MetS in patients having musculoskeletal pain seems common and interrelated.However, to our knowledge, manifestations with clinical symptoms of MetS, some inflammatory markers via serum concentrations and physical and psychological health profiles of patients with seeking treatment from outpatient physical therapy for musculoskeletal pain conditions have not been researched up to now.

Conditions

• Metabolic Syndrome

Interventions

Type	Name	Description
OTHER	Body composition	evaluated by Bodystat®1500 Bio-impedance Analyzer
OTHER	Physical activity level	assessed by the International Physical Activity Questionnaire-7
OTHER	Musculoskeletal pain intensity	evaluated with Visual Analog Scale
OTHER	Quality of life	assessed by the Nottingham Health Profile
OTHER	Psychological Well-Being	assessed by the Hospital Anxiety and Depression Scale
DIAGNOSTIC_TEST	Blood tests	Blood tests included serum glucose, triglyceride, high-density lipoprotein cholesterol (HDL-C), and uric acid levels. Blood samples were collected from the patients after one night of fasting.

Timeline

• Start date: 2015-08-01
• Primary completion: 2017-11-30
• Completion: 2017-12-30
• First posted: 2017-11-09
• Last updated: 2017-11-17

Locations

2 sites across 1 country: Turkey (Türkiye)